<p>We treated B10 recipient mice as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0004116#pone-0004116-g001" target="_blank">Fig. 1</a>. Cell suspensions from their spleen and tumor were obtained on day 10, 13 and 15, and stained with H7<sup>a</sup> tetramers and anti-CD8 antibody. A) Proportion and B) absolute numbers of H7<sup>a</sup> tetramer-positive CD8 T cells in 3–5 mice studied at each time point. * <i>P</i><0.01; § <i>P</i><0.001.</p
<p>Immune cells in the spleen were analyzed after tumor bearing C57BL/6 mice were treated with salin...
<p>(<b>a</b>) Spleens from mice in each treatment group were stained to determine CD3<sup>+</sup>/CD...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
<p>We studied mice from the four experimental groups described in <a href="http://www.plosone.org/ar...
<p>We studied four experimental groups: i) B10.H7<sup>b</sup> and B10 mice successfully treated for ...
BACKGROUND: Injection of CD8 T cells primed against immunodominant minor histocompatibility antigens...
<p>(A) The frequency of tumor reactive CD8<sup>+</sup> T cells was determined by staining with K<sup...
<p>(A and B) The frequency of tumor cells in the spleens of tumor transplanted Jalpha18<sup>−/−</sup...
<p>(<b>A</b>) Wt mice were inoculated with 1×10<sup>5</sup> B16-OVA cells and injected with 5×10<sup...
C57BL/6 (WT) and PLT2 mice were challenged with B16.OVA tumor cells. CFSE-labelled OT-I T cells were...
<p><b>A</b>. The mouse model ACT regimen that uses OT1 tumor antigen specific CD8<sup>+</sup> T cell...
<p>Tumor cells were infected with VV-VSV-Np<sub>52–59</sub> overnight and were γ-irradiated. The cel...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p>(A-C) Rag<sup>-/-</sup> and Rag<sup>-/-</sup>IL-7R<sup>-/-</sup> mice were reconstituted with 7–1...
<p>C57BL/6 mice (n = 3 per group) were implanted with unilateral subcutaneous B16-F10 tumor cells. T...
<p>Immune cells in the spleen were analyzed after tumor bearing C57BL/6 mice were treated with salin...
<p>(<b>a</b>) Spleens from mice in each treatment group were stained to determine CD3<sup>+</sup>/CD...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
<p>We studied mice from the four experimental groups described in <a href="http://www.plosone.org/ar...
<p>We studied four experimental groups: i) B10.H7<sup>b</sup> and B10 mice successfully treated for ...
BACKGROUND: Injection of CD8 T cells primed against immunodominant minor histocompatibility antigens...
<p>(A) The frequency of tumor reactive CD8<sup>+</sup> T cells was determined by staining with K<sup...
<p>(A and B) The frequency of tumor cells in the spleens of tumor transplanted Jalpha18<sup>−/−</sup...
<p>(<b>A</b>) Wt mice were inoculated with 1×10<sup>5</sup> B16-OVA cells and injected with 5×10<sup...
C57BL/6 (WT) and PLT2 mice were challenged with B16.OVA tumor cells. CFSE-labelled OT-I T cells were...
<p><b>A</b>. The mouse model ACT regimen that uses OT1 tumor antigen specific CD8<sup>+</sup> T cell...
<p>Tumor cells were infected with VV-VSV-Np<sub>52–59</sub> overnight and were γ-irradiated. The cel...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p>(A-C) Rag<sup>-/-</sup> and Rag<sup>-/-</sup>IL-7R<sup>-/-</sup> mice were reconstituted with 7–1...
<p>C57BL/6 mice (n = 3 per group) were implanted with unilateral subcutaneous B16-F10 tumor cells. T...
<p>Immune cells in the spleen were analyzed after tumor bearing C57BL/6 mice were treated with salin...
<p>(<b>a</b>) Spleens from mice in each treatment group were stained to determine CD3<sup>+</sup>/CD...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...